↓ Skip to main content

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

Overview of attention for article published in Diabetologia, September 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy
2 policy sources
patent
9 patents

Citations

dimensions_citation
512 Dimensions

Readers on

mendeley
211 Mendeley
citeulike
1 CiteULike
connotea
1 Connotea